Gillani Syed Wasif, Azeem Eman, Siddiqui Ammar, Mian Rashid Iqbal, Poh Vinci, Sulaiman Syed Azhar Syed, Baig Mirza Rafiullah
College of Pharmacy, Taibah University, Al Madinah Al Munawarah, Saudi Arabia.
Curr Diabetes Rev. 2016;12(3):279-84. doi: 10.2174/1573399811666150520094631.
BACKGROUND/AIM: Diabetes mellitus (DM) is a considerable systemic metabolic disorder to exhibit various metabolic and cardiovascular disorders, mainly hyperglycemia. Our study aims to evaluate oxidative stress markers in DM patients and to determine the clinical correlates affecting the investigational parameters.
To evaluate oxidative stress, the following parameters were included: tri-glycerides(TG), total cholesterol, low density lipoprotein cholesterol(LDL), oxidized LDL cholesterol(Ox LDL), superoxide dismutase(SOD), glutathione peroxidase(GSH-Px) and plasminogen activator inhibitor(PAI) which were measured at single observation point. Patient clinical and demographic data were taken from registered medication profiles from the Outpatient Department.
The diabetic subjects have significantly high measured values of endocrine(p<0.01), metabolic(p<0.01) and antioxidant parameters(p<0.05), and have significant higher values of TG(3.69±1.27 vs 1.79±0.84 mmol/L, p< 0.01), Ox LDL(85.37±19.1 vs 77.11±26.64 mmol/L, p<0.05) and SOD enzyme activity(918.78 ± 145.39 vs 880.08±149.52 U/g Hb, p<0.05) compared to the controls. A significant negative correlation was found between Ox LDL and HbA1c(r = -0.6782, p < 0.001) among diabetic subjects.
Elevated Ox-LDL, SOD and GSH-Px are associated with the diabetic patients. However, oxidative stress threshold values also showed high oxidative activity markers among controls. Clinical variables showed predictive information on oxidative activity among diabetes patients.
背景/目的:糖尿病(DM)是一种严重的全身性代谢紊乱疾病,会出现各种代谢和心血管疾病,主要表现为高血糖。我们的研究旨在评估糖尿病患者的氧化应激标志物,并确定影响研究参数的临床相关性。
为评估氧化应激,纳入了以下参数:甘油三酯(TG)、总胆固醇、低密度脂蛋白胆固醇(LDL)、氧化型低密度脂蛋白胆固醇(Ox LDL)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)和纤溶酶原激活物抑制剂(PAI),这些参数在单一观察点进行测量。患者的临床和人口统计学数据来自门诊部登记的用药记录。
糖尿病患者的内分泌(p<0.01)、代谢(p<0.01)和抗氧化参数(p<0.05)测量值显著较高,与对照组相比,TG(3.69±1.27 vs 1.79±0.84 mmol/L,p<0.01)、Ox LDL(85.37±19.1 vs 77.11±26.64 mmol/L,p<0.05)和SOD酶活性(918.78 ± 145.39 vs 880.08±149.52 U/g Hb,p<0.05)的值也显著更高。在糖尿病患者中,Ox LDL与糖化血红蛋白(HbA1c)之间存在显著负相关(r = -0.6782,p < 0.001)。
氧化型低密度脂蛋白(Ox-LDL)、超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-Px)升高与糖尿病患者有关。然而,氧化应激阈值在对照组中也显示出高氧化活性标志物。临床变量显示了糖尿病患者氧化活性的预测信息。